pyrimethamine has been researched along with Polycystic Kidney, Autosomal Dominant in 1 studies
Maloprim: contains above 2 cpds
Polycystic Kidney, Autosomal Dominant: Kidney disorders with autosomal dominant inheritance and characterized by multiple CYSTS in both KIDNEYS with progressive deterioration of renal function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with pyrimethamine decreases cell proliferation in human ADPKD cells and blocks renal cyst formation in an adult and a neonatal PKD mouse model." | 5.37 | Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. ( Frank, DA; Haque, N; Humphreys, BD; Nelson, EA; Takakura, A; Zandi-Nejad, K; Zhou, J, 2011) |
| "Treatment with pyrimethamine decreases cell proliferation in human ADPKD cells and blocks renal cyst formation in an adult and a neonatal PKD mouse model." | 1.37 | Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. ( Frank, DA; Haque, N; Humphreys, BD; Nelson, EA; Takakura, A; Zandi-Nejad, K; Zhou, J, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takakura, A | 1 |
| Nelson, EA | 1 |
| Haque, N | 1 |
| Humphreys, BD | 1 |
| Zandi-Nejad, K | 1 |
| Frank, DA | 1 |
| Zhou, J | 1 |
1 other study available for pyrimethamine and Polycystic Kidney, Autosomal Dominant
| Article | Year |
|---|---|
Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways.
Topics: Adult; Aminosalicylic Acids; Animals; Animals, Newborn; Benzenesulfonates; Cell Line; Cysts; Disease | 2011 |